RQN-16465-59329 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-08-04
Dose 1 — Moderna
2022-08-05
Registered in v-safe
2022-08-05
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · Site: Pain · Irritability/crying

Under 3 check-in
2022-08-07
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-08-08
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · Site: Pain · None

Under 3 check-in
2022-08-09
Survey response — days 1–6 daily, dose 1, under 3
MedDRA: Headache — Feeling: Good

Free text: Headache

MedDRA releases: 2024-11 · check-in free text available
2022-08-15
Health check-in — day 7, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-08-20
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-08-25
Survey response — day 21, dose 1, under 3
MedDRA: Nasal congestion — Feeling: Good

Free text: Stuffy nose

MedDRA releases: 2024-11 · check-in free text available
2023-02-02
Health check-in — 6 months, dose 1, under 3
Feeling: Fair

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-08-04	Moderna	No

Free text

Release 12 (Under 3) — days 1–6 daily, dose 1, under 3

2022-08-09

Systemic reaction (other): Headache

Release 12 (Under 3) — day 21, dose 1, under 3

2022-08-25

Symptoms: Stuffy nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Nasal congestion	·	·	✓
SRO	Headache	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release